Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Medical Innovation: President Trump Signs New FDA User Fee Agreement into Law; PhRMA and BIO Applaud the Move

8/25/2017

0 Comments

 
Washington, DC — President Donald J. Trump on August 18 signed into law a funding package for the Food and Drug Administration (FDA) that also takes steps to lower drug prices.
 
The FDA Reauthorization Act (FDARA) of 2017 reauthorizes a program in which drug and medical device makers pay the FDA a fee for every new product application.  The agency uses those funds to hire more people and speed up approvals.
 
The user fee program must be reauthorized every five years. The current program expires at the end of September, and if it hadn't been signed into law before then, the agency would have had to lay off workers.
​The law also includes a measure that lets the FDA hasten development of a generic drug if an off-patent product with no competition is being sold at an egregiously high price.
 
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl issued the following statement following the President’s signing the bill:
 
“PhRMA commends President Trump for signing into law the FDA Reauthorization Act of 2017 (FDARA), which includes the Prescription Drug User Fee Amendments of 2017 (PDUFA VI), as well as the biosimilar and generic drug user fee amendments.  
 
“In today’s new era of medicine, where breakthrough science is transforming patient care, today’s signing of FDARA is a major victory for the patients in need of innovative, lifesaving treatments.
 
“By reauthorizing PDUFA and the other user fees, the administration is leading the way toward greater efficiency at the U.S. Food and Drug Administration (FDA) and increasing competition in the biopharmaceutical market.
 
“We further appreciate the leadership that Health and Human Services Secretary Tom Price and FDA Commissioner Scott Gottlieb demonstrated throughout this reauthorization process.”
 
Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood also released a statement the same day:
 
“President Trump’s signature today on this landmark legislation is the culmination of a years-long collaborative process in which patients, industry, FDA, legislators and other stakeholders worked tirelessly to identify ways in which FDA’s human drug review programs can be improved to deliver better health care for every American and enhance the incorporation of the patient voice in drug development and review. 
 
“BIO is proud to have played a part in these efforts and prouder still of the important advances for patients and medical innovation that this law will help achieve. Whether it be bringing patients’ perspectives more closely to bear in regulatory decision-making, speeding new medicines to market by making the clinical trial process more efficient, or increasing competition from generics and biosimilars, the provisions of this law will make our healthcare system more responsive to the needs of patients.
 
“We look forward to working with Commissioner Gottlieb to ensure that these critical advancements are most effectively implemented. We thank the leaders from both parties and in both chambers of Congress for their tireless bipartisan efforts in crafting this historic achievement.”
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619